BACKGROUND: Transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC) has been associated with improved long-term dysphagia symptomatology compared with chemoradiation. Dysphagia in the perioperative period has been inadequately characterized. The objective of this study was to characterize short-term swallowing outcomes after TORS for OPSCC. METHODS: Patients undergoing TORS for OPSCC were enrolled prospectively. The Eating Assessment Tool 10 (EAT-10) was used as a measure of swallowing dysfunction (score >2) and was administered on postoperative day (POD) 1, 7, and 30. Patient demographics, weight, pain level, and clinical outcomes were recorded prospectively and focused on time to oral diet, feeding tube placement, and dysphagia-related readmissions. RESULTS: A total of 51 patients were included with pathologic T stages of T1 (n 5 24), T2 (n 5 20), T3 (n 5 3), and Tx (n 5 4). Self-reported preoperative dysphagia was unusual (13.7%). The mean EAT-10 score on POD 1 was lower than on POD 7 (21.5 vs 26.6; P 5 .005) but decreased by POD 30 (26.1 to 12.2; P < .001). Forty-seven (92.1%) patients were discharged on an oral diet, but 57.4% required compensatory strategies or modification of liquid consistency. Ninety-eight percent of patients were taking an oral diet by POD 30. There were no dysphagia-related readmissions. CONCLUSION: This prospective study shows that most patients who undergo TORS experience dysphagia for at least the first month postoperatively, but nearly all can be started on an oral diet. The dysphagia-associated complication profile is acceptable after TORS with a minority of patients requiring temporary feeding tube placement. Aggressive evaluation and management of postoperative dysphagia in TORS patients may help prevent dysphagia-associated readmissions.
INTRODUCTION
Since gaining US Food and Drug Administration approval in 2009, the use of transoral robotic surgery (TORS) for the resection of oropharyngeal squamous cell carcinoma (OPSCC) has increased. 1 Although concurrent chemoradiation for OPSCC is still considered the standard of care based on improved locoregional control compared with radiation alone, there is renewed interest in surgical management of OPSCC due to known long-term potential for severe late toxicity from chemoradiation. [2] [3] [4] A recent multi-institutional study reported excellent (94.5%) 2-year disease-specific survival after TORS with risk-adjusted adjuvant therapy for OPSCC, which compares favorably with survival after nonsurgical management. 5 Although there are no prospective clinical trials comparing survival outcomes between the two treatment arms, meta-analyses of published data suggest equivalent survival between TORS and risk-adjusted adjuvant therapy and radiotherapy. 6, 7 Because of this apparent equipoise, clinical trials currently underway are focused on ability of TORS to allow for deintensification of adjuvant radiation (Eastern Cooperative Oncology Group [ECOG] 3311) or on comparison of long-term functional outcomes between surgical and nonsurgical treatment strategies (ORATOR) among several others. 8, 9 Given that the incidence of HPV-associated OPSCC has increased and that these patients tend to be younger and healthier and can expect to have good prognosis for long-term survival, functional outcomes are increasingly important. 10 Although intermediate-and long-term dysphagia after TORS has been reported previously by several groups, including ours, no studies have systematically described short-term dysphagia after TORS for OPSCC. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Immediate postoperative dysphagia outcomes are rarely reportedand when they are reported, they are only present at one data point. 16, 17, 19 In a review of our departmental TORS database in 2014 we found that dysphagia-related readmissions occurred in 6.3% of cases, which is similar to reported rates of dysphagia-related readmissions after TORS for OPSCC reported in the literature, which ranges from 4.7% to 7.8%. 18, 21, 22 This prompted the design of a quality improvement intervention to standardize swallowing evaluation after TORS for OPSCC and to prospectively follow these patients and assess their swallowing outcomes in the first month after TORS. Therefore, the objective of this study is to prospectively describe short-term dysphagia after TORS for OPSCC. Our primary outcome measure was defined as change in Eating Assessment Tool-10 (EAT-10) scores over the first month of recovery. Our secondary outcome measures included change in pain scores and weight over 1 month, time to transition to an oral diet, need for feeding tube placement, need for any compensatory swallowing strategies, and dysphagia-related readmissions.
METHODS
This prospective clinical study was approved by the University of Pittsburgh Institutional Review Board. Patients undergoing TORS for resection of OPSCC between June 2014 and March 2016 were enrolled into the study prospectively. Exclusion criteria were history of previous TORS, repeat TORS within 1 month after enrollment, TORS for nonmalignancy, a procedure on a nonoropharyngeal aerodigestive subsite, tracheotomy in the perioperative period, a contraindication to swallowing evaluation, or fewer than 2 points of follow-up data. All patients underwent a speech-language pathology evaluation on postoperative day (POD) 0 or 1 for appropriateness for oral diet as well as any dietary modifications or compensatory strategies needed with repeat evaluations in inpatient or outpatient setting as needed. Compensatory strategies and dietary modifications were used to eliminate clinical signs of aspiration present at the bedside and/or improve tolerance of oral intake secondary to pain. Modified barium swallow (MBS) or fiberoptic endoscopic evaluation of swallowing (FEES) was not used routinely. The EAT-10, a 10-item validated questionnaire measuring dysphagia severity, was used as a measure of swallowing dysfunction (a score of >2 is considered abnormal). 23, 24 This was administered on POD 1, POD 7, and POD 30. Only patients who had at least 2 administrations of the EAT-10 questionnaire were included in this study. Patient pain level (on a scale of 1 to 10) was recorded at the same time points, and patient weight was recorded at admission, POD 7, and POD 30. Patient demographics and clinical outcomes were recorded prospectively, with particular attention paid to need for dietary modifications, temporary feeding tube placement for alternative means of nutrition, and dysphagia-related readmissions (dysphagia, dehydration, pneumonia). Temporary feeding tubes used in this study were Dobhoff nasogastric tubes.
Demographic and baseline clinical characteristics including sex, age, T stage, N stage, alcohol use at diagnosis, smoking history, preoperative dysphagia, primary TORS site, and neck dissection were summarized. The categorical variables were tested for association with EAT-10 score on POD 30 using either the Wilcoxon MannWhitney or Kruskal-Wallis test, and a Spearman correlation coefficient was used to test for association of EAT-10 score at POD 10 with age and N stage.
Paired t tests were used to compare changes in EAT-10 scores, weight, and pain levels from baseline to POD 7 and POD 30. Results were based on 2-tailed tests and were considered significant at P < .05. Analyses were performed in SAS 9.4 (SAS Institute, Cary, NC) and in R version 3.1.1.
RESULTS
During the study time period, 89 patients underwent TORS for OPSCC and met our inclusion criteria (Fig. 1) . Seventy-seven of these patients underwent a speechlanguage pathology evaluation on POD 0/1, and 26 of these patients did not meet our study criteria (3 for previous TORS, 6 for repeat TORS within 1 month, 9 for fewer than 2 data points, 6 for complicated postoperative courses and/or tracheotomy precluding accurate swallowing evaluation, 2 for preexisting neurologic dysfunction). Twelve patients met the above criteria but did not undergo a speech-language pathology evaluation during their initial hospitalization and were thus not included. This left 51 patients for analysis whose baseline characteristics are depicted in Table 1 . There were 41 males and 10 females with a median age of 58 years (range, 40-74 years). Thirty (59%) patients underwent TORS tonsillectomy with the remainder undergoing base of tongue resection. Forty-three (84%) patients underwent concurrent or staged neck dissection. Forty-four (86%) patients were pathologically staged as T1/T2, although 3 patients were T3 and 4 patients were Tx after bilateral tonsillectomy and base of tongue resection. Fifty (98%) patients were p16-positive. Fifty patients underwent a clinical swallowing evaluation on POD 0 or POD 1 and had at least 1 follow-up data point (POD 7 [n 5 50] and/or POD 30 [n 5 47]). One patient did not complete the EAT-10 on POD 1 due to alcohol withdrawal.
Self-reported preoperative dysphagia was unusual (7/51 [14%]). Although preoperative instrumental testing was not routine, 19 patients had a preoperative MBS as part of the protocol of ECOG 3311, with 8/19 (42%) having some abnormality noted that was generally mild. The primary abnormality noted was premature spillage (6/8), attributed to poor posterior oral bolus control. One patient did demonstrate preprandial aspiration with thin liquids; however, this patient was observed to be in a retroflexed head position when this event occurred. No incidence of aspiration was observed when the patient's head was properly positioned in the head neutral position. One additional patient demonstrated deep laryngeal penetration without aspiration, secondary to diminished base of tongue strength and decreased hyolaryngeal elevation. Incidence of laryngeal penetration was eliminated with the use of compensatory strategies.
Mean EAT-10 scores increased significantly from POD 1 to POD 7 (21.5-26.6; P 5 .005) but decreased by POD 30 (26.1-12.2, P < .001) (Fig. 2) . The mean EAT-10 total score decreased, on average, 8.9 points from POD 1 to POD 30 (P < .0001). 5/48 (11%) patients had an EAT-10 score of <3 at 1 month.
Thirty-one patients had individual EAT-10 component scores recorded prospectively ( Table 2) . Each of the questions showed an average decrease from POD 1 to POD 30 with the exception of "lose weight." The greatest decrease was seen in "painful swallowing," with a mean decrease of 1.7.
Subject weight decreased, on average, from POD 0 to POD 7 (mean weight, 207.6 and 198.2 lbs, respectively; P < .001) but there was no change in weight between POD 7 and POD 30 (198.8 and 199.7 lbs, respectively; P 5 .45). The mean percentage change in body weight at (Fig. 4) . Forty-five (88.2%) patients were started on an oral diet based on a clinical swallow evaluation (POD 0 or POD 1). Two additional patients were started on an oral diet by the time of discharge: 1 patient remained intubated until POD 1 and was started on a diet on POD 2, and 1 patient was kept non per os (NPO) until POD 3 due to anxiety and discomfort with swallowing and ultimately had feeding tube placed to supplement inadequate oral intake. Four additional patients remained NPO until outpatient swallowing evaluation (these 4 patients were cleared for oral intake on POD 12, 15, 18, and 21, respectively).
Six patients (11.8%) required a temporary feeding tube. Two were placed prophylactically at the time of surgery, 2 on POD 1 for poor oral intake, and 2 on POD 3 for poor oral intake. Tube feedings were removed an average of 15.6 days postoperatively (range, 3-31 days). One patient required tube feedings through adjuvant therapy.
Of the 47 patients cleared per os intake during their inpatient status, 45 (95.7%) required a soft or pureed consistency for solids. Thirty-nine (82.9%) of these patients Original Article were able to safely consume thin liquids, whereas 8 (17.1%) required nectar-or honey-thickened consistency. Twenty-five (53.1%) patients required postural maneuvers for swallowing such as rotation with or without chin tuck, liquid wash, or effortful swallow. Strategies were used to mitigate clinical signs of aspiration (eg, coughing or throat clearing) and/or to improve reported pain associated with swallowing. Overall, 27 (57.4%) patients required either compensatory strategies or modification of liquid consistency for safe oral intake. By 1 month, 50 of the 51 (98.0%) patients were taking an oral diet and 41 (80.4%) patients were taking a regular diet. One patient remained feeding tube dependent at the end of 1 month. Eight of 16 (50.0%) patients who underwent planned 1-month MBS had abnormalities noted-primarily premature spillage, transient laryngeal penetration, or incomplete clearance of bolus-and 1 (6.25%) of these patients had aspiration with thin liquids noted.
Five of the 51 (9.8%) patients required readmission within 30 days, 4 for postoperative hemorrhage and 1 for nephrolithiasis. None of these readmissions were dysphagia-related.
On univariate analysis, only self-reported preoperative dysphagia was associated with a higher EAT-10 score at 30 days (median, 19 [interquartile range (IQR), 10-30] vs 9.5 [IQR, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] days; P 5 .04) ( Table 3) . Those patients who required a temporary feeding tube also had higher mean EAT-10 score at 30 days (median, 28 (IQR, 21-30) vs 9.5 (IQR, 4-17) days; P 5 .005). There was no difference predicted by age, sex, T stage, N stage, primary subsite, neck dissection, or history of radiation therapy.
Among the 3 patients with T3 primary tumors, all were able to be started on an oral diet with thin liquids on POD 1. None of them required temporary feeding tube placement.
DISCUSSION
In this prospective cohort study, we describe the expected short-term postoperative swallowing outcomes after patients undergo uncomplicated TORS for oropharyngeal malignancy. Our primary outcome measure was change in EAT-10 scores over time, and we found a significant increase in EAT-10 score from POD 1 to POD 7, as well as a substantial decrease by POD 30. Although there are limited data on swallowing outcomes in the TORS literature after resection of OPSCC, the 2 studies we identified that have reported data within that time period reported improved but not normalized HRQOL and MDADI scores by 3 weeks. 16, 17 This is consistent with our data, which show that 34 of 46 (73.9%) patients and 42 of 46 (91%) patients will have improved EAT-10 scores by 1 month compared with POD 1 and POD 7, respectively. Despite significant improvement by POD 30, only 10% of patients normalized (EAT-10 score <3), suggesting that normal swallowing function should not be expected by 1 month and, by extrapolation, the start of radiation therapy. In those patients who do not receive adjuvant chemoradiation therapy, others have reported normalization of patient-reported swallowing outcome measures by 3 months. 11, 20 Most (45 [88.2%]) of the patients in our study were started on an oral diet by POD 1, whereas 46 (90.1%) patients were discharged on an oral diet (1 patient required feeding tube placement once cleared for an oral diet and 2 patients were cleared for oral intake on POD 2 and 3 before discharge). Despite continued elevation of EAT-10 scores at 1 month after TORS, 98% of patients are able to be continued on an oral diet without the need for tube feeding supplementation, and 80% of patients are able to take a regular diet. This is higher than previously reported in the literature, with 69%-73% of patients reporting beginning oral intake before discharge, 83% by week 2, and 89% by 1 month. 18, [25] [26] [27] Our feeding tube placement rate was 11.8%, with the majority of these patients requiring feeding tube placement in the postoperative setting due to inability to tolerate an oral diet safely as determined by speech-language pathology or to supplement oral intake. Feeding tube placement rates in the literature vary widely in reported series from 3% to 100%, with a mean placement rate of 33% with several groups still advocating for routine intraoperative feeding tube placement. 25 However, based on these results, we believe that feeding tube placement can be safely avoided in the majority of patients.
The time to oral intake and feeding tube rates are lower compared with previously reported series, which could be related to several factors. The inclusion of only those patients with uncomplicated postoperative courses may explain some of this difference, although only 6 such patients were excluded for this reason and of our entire TORS experience over this time period, 18.5% of patients required a temporary feeding tube, which is still well below previous reported frequencies. Similarly, our practice of a team-based approach with a speech-language pathology evaluation of each patient for swallowing dysfunction and appropriate diet as well as any compensatory strategies needed could have allowed more patients to be started on a safer diet sooner. Given that in this series, 57.4% of patients required compensatory strategies or were not able to tolerate thin liquids safely, we would advocate routine speech-language pathology evaluation in the postoperative setting after TORS for OPSCC. We believe that among appropriately selected patients, oral intake should be the expectation before discharge and that nearly all patients can be expected to have begun oral intake within 1 month.
Dysphagia-related readmissions after TORS, most notably aspiration pneumonia, are not common, Original Article although they are inconsistently reported within the TORS literature. Among those who have reported it, the readmission rate ranges from 4.7% to 7.8% 18, 21, 22 . This is similar to our past experience of a 6.3% dysphagiarelated readmission rate. After our initiation of this quality improvement initiative, we did not have any dysphagiarelated readmissions or incidences of aspiration pneumonia. Whether this is due to more careful evaluation of dysphagia in the immediate postoperative setting or to better surgical technique or patient selection or chance is unclear. Regardless, this should continue to be an area of active evaluation and quality improvement among TORS surgeons.
Reporting of objective swallowing outcomes with instrumental testing such as MBS or FEES has been identified as an area of need within the TORS literature. 25 Instrumental testing was not necessary before initiation of diet in the immediate postoperative setting. However, among those who were discharged with a feeding tube, MBS or FEES was used in all cases before initiation of diet. Additionally, in a subset of our cohort, a planned 1-month MBS was obtained as part of the protocol of ECOG 3311. 8 Eight of 17 patients who underwent planned postoperative MBS exhibited abnormalities. Of these patients, 5 (63%) had demonstrated dysphagia on preoperative MBS. The primary characteristics were again noted to be premature spillage, as well as transient penetration. The incidence of deep laryngeal penetration or aspiration did not increase. Patients were, however, observed to have increased pharyngeal residue compared with initial MBS. One patient who required a feeding tube did have new aspiration of thin liquids postoperatively on planned MBS. Interestingly, abnormalities on preoperative MBS such as premature spillage, penetration, or post-swallow residuals did not predict postoperative outcomes, including EAT-10 score, weight loss, or need for feeding tube. Self-reported preoperative dysphagia, on the other hand, was predictive of needing postoperative feeding tube (42.9% vs 6.8%) and 1-month EAT-10 score, but there was no difference in weight loss. Thus, patients with preoperative subjective dysphagia should be counseled that they are at risk of worsened short-term swallowing outcomes.
Strengths of this study are its prospective nature and minimal loss to follow-up. Limitations of this study include the lack of preoperative EAT-10 scores. Although self-reported preoperative dysphagia was unusual in this study, others have reported abnormalities in up to 40% of preoperative TORS patients screened with the MD Anderson Dysphagia Index. 17 Our experience is that most TORS patients have small HPV-related tumors and, as such, have limited self-reported dysphagia before surgery. This is borne out in our data (14% self-report dysphagia). Also, although not part of the design of the study, 32 TORS patients (including 19 in this cohort) have preoperative EAT-10 scores, with 27 (85%) of these patients in the normal range. Our objective of the study was to show the natural course of swallowing symptomatology after TORS, which has been inadequately characterized to this point. Not having baseline data certainly limits the interpretability of the 30-day EAT-10 score as it relates to the patient baseline, but we do not think it limits interpretation of the trends in the postoperative period. Although our study is also limited by the lack of a functional swallowing assessment, we think that functional swallowing assessment is not necessary in the vast majority of TORS (oropharynx) patients. Most patients who do not have a tracheotomy and who are not frail at baseline do quite well from a swallowing standpoint, as was evident in our study. Only 4 patients required functional swallowing testing before initiation of diet. Among the 51 patients assessed in this study, there were no dysphagia-related readmissions or episodes of aspiration pneumonia. Thus, we think that careful bedside swallowing evaluation by a trained speech-language pathologist is a safe first step and that functional swallowing assessment can be reserved for those patients for whom there remains concern for potential aspiration. However, there will remain doubt until prospective functional swallowing assessment data on TORS patients are published. Fortunately, these data are being collected as part of the protocol of ECOG 3311 and should be available when that study population is mature. Although we recognize that another limitation is its lack of inclusion of patients with complicated postoperative course, we feel this work can be generalized to most patients undergoing TORS for OPSCC.
Furthermore, other symptomatology that may be germane to patients undergoing TORS including trismus and velopharyngeal insufficiency was not assessed in this study and we would advocate for further prospective data in these areas.
In conclusion, dysphagia is common in the first month after TORS when patients are followed prospectively. Despite elevated EAT-10 scores up to a month postoperatively, adverse dysphagia-related outcomes are rare. Evaluation for dysphagia should be considered routine in this cohort of patients given the prevalence of dietary modifications and compensatory strategies needed.
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